apoF Inhibitors
Chemical inhibitors of apoF function by disrupting the cellular lipid environment and membrane structures that are vital to the protein's activity. Chlorpromazine has the capacity to disrupt lipid rafts within cellular membranes, which can impair apoF's ability to interact with lipids and inhibit its function. Similarly, Filipin and Nystatin, by binding to membrane cholesterol, can extract this essential component from lipid rafts, potentially leading to the inhibition of apoF's activities associated with these microdomains. Lovastatin and Simvastatin, both HMG-CoA reductase inhibitors, reduce the biosynthesis of cholesterol, which is a crucial element of lipid rafts. The resulting destabilization of these rafts can indirectly inhibit the function of apoF by affecting its interaction with lipids. Probucol, with its capacity to decrease plasma cholesterol and LDL levels, may affect the lipid composition of the cell membrane and lipid rafts, thereby influencing apoF's lipid-related activities.
Continuing with the theme of lipid raft disruption, Cyclodextrin and Methyl-β-cyclodextrin are notable for their ability to extract cholesterol from plasma membranes, which can alter the lipid environment essential for apoF's operation. U18666A, which inhibits cholesterol transport, can also disrupt intracellular cholesterol distribution and lipid rafts, further impeding apoF's ability to associate with lipids and carry out its normal function. Lastly, Ezetimibe, by inhibiting the intestinal absorption of cholesterol, can reduce cholesterol levels in the body, thus destabilizing lipid rafts and indirectly inhibiting the cholesterol-dependent functions of apoF within these specialized regions of the membrane.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a cationic amphiphilic drug that can disrupt lipid rafts within cellular membranes. Since apoF is involved in lipid transport and may associate with lipid rafts, the disruption of these structures can impair apoF's ability to interact with lipids and inhibit its function. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Filipin is a polyene antibiotic that binds to cholesterol, which is a key component of lipid rafts. By extracting cholesterol from the membrane, filipin can disrupt lipid rafts and indirectly inhibit apoF's function related to lipid raft-mediated transport processes. | ||||||
Nystatin | 1400-61-9 | sc-212431 sc-212431A sc-212431B sc-212431C | 5 MU 25 MU 250 MU 5000 MU | $51.00 $129.00 $251.00 $3570.00 | 7 | |
Nystatin is another polyene antibiotic that binds to ergosterol and, by similarity, to cholesterol, disrupting membrane integrity and lipid rafts. This disruption can hinder apoF's lipid interactions and functional capabilities. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin is an HMG-CoA reductase inhibitor that reduces cholesterol biosynthesis. By lowering cholesterol levels, it can destabilize lipid rafts and indirectly inhibit apoF's cholesterol-dependent functions. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin, similar to lovastatin, inhibits cholesterol synthesis and can lead to the destabilization of lipid rafts, potentially impairing apoF's lipid binding and transport activities. | ||||||
Probucol | 23288-49-5 | sc-203666 sc-203666A | 100 mg 1 g | $79.00 $166.00 | 5 | |
Probucol decreases plasma cholesterol and LDL levels, which could indirectly affect the lipid composition of membranes and lipid rafts, thereby inhibiting apoF's lipid-related activities. | ||||||
β-Cyclodextrin | 7585-39-9 | sc-204430 sc-204430A | 25 g 500 g | $60.00 $538.00 | 3 | |
Cyclodextrin extracts cholesterol from plasma membranes, disrupting lipid rafts. This can indirectly inhibit apoF by altering the lipid environment it operates within. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Methyl-β-cyclodextrin selectively removes cholesterol from membranes, which can disrupt lipid rafts and thereby inhibit apoF's function by altering its lipid transport and binding properties. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
U18666A is a cholesterol transport inhibitor that can disrupt intracellular cholesterol distribution and lipid rafts. This disruption could impede apoF's ability to associate with lipids and inhibit its function. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Ezetimibe specifically inhibits the intestinal absorption of cholesterol. By reducing the overall cholesterol levels, it can destabilize lipid rafts and indirectly inhibit apoF's cholesterol-dependent functions within these microdomains. | ||||||